What you should know:
1. Clinicians must weigh the risk of vision loss without treatment against the potential for COVID-19 transmission.
2. Retinal specialists see a high-risk population that could develop serious COVID-19-related complications.
3. The society’s guidance follows in the footsteps of the American Academy of Ophthalmology, which recommended ophthalmologists and other eye care providers abstain from seeing patients or performing elective procedures during this time.
4. ARS recommends retinal specialists only see patients who require essential treatments. Such treatments include emergency treatment, intravitreal injection therapy and early postoperative follow-up. The society also recommends clinicians use telephone triage to ensure patients aren’t at high-risk for contracting COVID-19.
More articles on ASC news:
Regent Surgical Health responds to COVID-19: 3 things to know
When will the coronavirus peak? It’s complicated
Hospitals looking into using ASCs for COVID-19 patients: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.